MedAmerica, Inc. Offers Comprehensive Influenza Data for Health Care Planning [Primary member]
submitted by kickingbird at Apr, 23, 2005 from PRNewswire
Valuable information regarding influenza and flu-like illnesses based on statewide clinical experience is now available to medical professionals. Gathered from 800 California physicians and 300 physician ... MedImmune Reports Financial Results for First Quarter 2005 [Primary member]
submitted by kickingbird at Apr, 22, 2005 from PRNewswire
Recent Highlights * Sales of Synagis(R) increased 12 percent to $472 million * FluMist supplements approved by FDA to reduce normal allantoic fluid ... Denka Seiken to Market Influenza Vaccine Through Takeda Pharmaceutical [Primary member]
submitted by kickingbird at Apr, 20, 2005 from The Japan Corporate News Network (via http://www.japancorp.net/Article.Asp?Art_ID=9891)
Tokyo (JCNN) - Denka Seiken (TSE: 4561) announced on April 18 that it has agreed with Takeda Pharmaceutical (TSE: 4502) to collaborate in the sale of its influenza vaccine. Specifically, Denka Seiken will ... Sinovac Biotech Ltd. Issues Corporate Update [Primary member]
submitted by kickingbird at Apr, 19, 2005 from PRNewswire
BEIJING--(BUSINESS WIRE)--April 18, 2005--Sinovac Biotech Ltd. ("Sinovac") ("the Company") (AMEX:SVA) today updates on the status of the vaccines comprising its product portfolio.
Hepatitis A - Healive(TM) ... Amarillo Biosciences, Inc. Announces Progress Report to Shareholders and Annual Meeting Agenda [Primary member]
submitted by kickingbird at Apr, 19, 2005 from PRNewswire (via http://www.marketwire.com/mw/release_html_b1?release_id=8483)
AMARILLO, TX -- (MARKET WIRE) -- 04/18/2005 -- Amarillo Biosciences, Inc. (ABI) (OTC BB: AMAR) announces that proxy material is being mailed to its approximately 1,400 shareholders of record as of April ... Roche Files Supplemental New Drug Application to Extend Prophylaxis Indication for Tamiflu(R) to Patients Between One to 12 Years of Age [Primary member]
submitted by kickingbird at Apr, 19, 2005 from PRNewswire (via http://biz.yahoo.com/prnews/050418/nym048.html?.v=7)
NUTLEY, N.J., April 18 /PRNewswire/ -- Roche has filed a supplemental new drug application (sNDA) with the U.S. Food and Drug Administration (FDA), requesting an extension of the prophylaxis indication ... Sanofi pasteur Awarded $97 Million HHS Contract to Accelerate Cell-Culture Pandemic Influenza Vaccine Development [Primary member]
submitted by kickingbird at Apr, 2, 2005 from businesswire
Major U.S. public health initiative complements sanofi pasteur´s leadership ... ID Biomedical to pursue U.S. accelerated approval process for its influenza vaccine [Primary member]
submitted by kickingbird at Mar, 16, 2005 from ID Biomedical (via http://www.newswire.ca/en/releases/archive/March2005/15/c469)
ID Biomedical Corporation (TSX: IDB;NASDAQ: IDBE) announced today that it has been advised by the United StatesFood and Drug Administration´s Center for Biologics Evaluation and Research(CBER) that ... Sinovac Biotech Ltd. Announces That it Has Received the New Drug Certificate From the Chinese Government for its Split Flu Vaccine [Primary member]
submitted by kickingbird at Mar, 16, 2005 from Sinovac
BEIJING--(BUSINESS WIRE)--March 15, 2005--Sinovac Biotech Ltd. ("Sinovac") ("the Company") (AMEX:SVA) announces that it has received the New Drug Certificate from the Chinese State Food and Drug Administration ... New Zealand:Sanofi pasteur statement on influenza vaccine [Primary member]
submitted by kickingbird at Mar, 16, 2005 from New Zealand Herald (via http://www.nzherald.co.nz/index.cfm?c_id=1&ObjectID=1011)
Sanofi pasteur has provided data to the New Zealand Ministry of Health demonstrating that its influenza vaccine, VAXIGRIP, has enough antigen, the substance that stimulates the production of protective ... Biota and Aerogen Sign Flu Development Agreement [Primary member]
submitted by kickingbird at Mar, 10, 2005 from PRNewswire
Biota Holdings Limited (ASX: BTA) and Aerogen, Inc. (Nasdaq: AEGN) today announced that theyhave signed an agreement for the development of CS-8958, one of the new LANI(long-acting neuraminidase inhibitor) ... sanofi pasteur Launches New Version of Its Pediatric Influenza Vaccine [Primary member]
submitted by kickingbird at Mar, 10, 2005 from yahoo news
For the 2005-2006 influenza season, sanofi pasteur, the vaccines business of the sanofi-aventis Group (NYSE: SNY), will offer a new formulation of pediatric influenza vaccine that contains no preservatives ... Biota boosted by UK flu stockpiling [Primary member]
submitted by kickingbird at Mar, 4, 2005 from Biota
Melbourne, Australia, 4 March 2005 ?Biota Holdings Limited (ASX:BTA) announced that the recent decision by the UK Government to stockpile nearly A$500 million of flu antivirals further demonstrates the ... Drug maker in talks to supply antiviral stockpile [Primary member]
submitted by kickingbird at Mar, 3, 2005 from Reuters (via http://msnbc.msn.com/id/7067756/)
ZURICH - Swiss drugmaker Roche Holding AG is in talks with a dozen countries, including the United States, to supply stockpiles of its Tamiflu drug to protect their populations against a possible bird ... Cambodian PM orders to ban poultry influx from Thai, Vietnam
submitted by kickingbird at Feb, 10, 2005 from Xinhua News Agency (via http://news.xinhuanet.com/english/2005-02/10/content_2568147)
Cambodian Prime Minister Hun Sen on Thursday signed an order to ban the influx of poultry from Thailand and Vietnam in order to prevent the spreading of bird fluinto Cambodia.
The ... Amersin Announces 30% Increase in Ribavirin Production to Meet Market Demand Following Recent Avian Flu Outbreaks in Asia [Primary member]
submitted by kickingbird at Jan, 30, 2005 from PR Web (via http://www.prweb.com/releases/2005/1/prwebxml202961.php)
Amersin is a public company listed on the US OTCBB under the trading symbol AMLS and in Germany on the Frankfurt Exchange under the trading symbol HUQ. Its subsidiary is increasing production of the antiviral ... Sanofi Pasteur Now Accepting Influenza Vaccine Orders For CDC´s Late-Season Stockpile [Primary member]
submitted by kickingbird at Jan, 28, 2005 from PRNewswire
Sanofi pasteur, thevaccines business of the sanofi-aventis Group, is now accepting orders fromhealth-care providers and distributors wishing to obtain vaccine from theCenters for Disease Control and Prevention´s ... Chiron posts Q4 loss [Primary member]
submitted by kickingbird at Jan, 27, 2005 from UNKNOW
Chiron Corp. posted a fourth-quarter loss Wednesday, falling short of Wall Street´s expectations.
The Emeryville-based biotechnology company, which was unable to deliver half the nation´s flu ... ID Biomedical begins development of pandemic influenza vaccine [Primary member]
submitted by kickingbird at Jan, 20, 2005 from PRNewswire (via http://biz.yahoo.com/prnews/050119/to237_1.html)
PRNewswire-FirstCall/ - ID Biomedical Corporation announced today that it has begun development of an experimental ("mock") vaccine against a strain of the influenza virus, H5N1, that experts believe could ... Crucell Joins Influenza Vaccine Supply (IVS) International Task Force [Primary member]
submitted by kickingbird at Jan, 14, 2005 from Crucell N.V (via http://biz.yahoo.com/pz/050114/70884.html)
Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (NasdaqNM:CRXL) announced today that it has been accepted as a new member of the Influenza Vaccine Supply (IVS) international task force.A specialized ... 130 items, 20/Page, Page[3/7][|<<] [|<] [1] [2] [3] [4] [5] [6] [7] [>|] [>>|] Search local
Northen China: Beijing - Gansu -
Hebei -
Heilongjiang -
Henan -
Hubei -
Inner mongolia -
Jilin -
Liaoning -
Ningxia -
Qinghai -
Shaanxi -
Shandong -
Shanxi -
Tianjin -
Xinjiang -
Xizang(Tibet)
Southen China: Anhui -
Chongqing -
Fujian -
Guangdong -
Guangxi -
Guizhou -
Hainan -
Hongkong -
Hunan -
Jiangsu -
Jiangxi -
Macao -
Shanghai -
Sichuan -
Taiwan -
Yunnan -
Zhejiang
|
- 
